Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Mastocytosis, Systemic × sarilumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Mastocytosis, Systemic 1 Arthritis, Rheumatoid 1

Interventions

sarilumab 1 obatoclax 1 nilotinib 1 midostaurin 1 ibrutinib 1 Everolimus 1 Brentuximab Vedotin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03770273 2024-12-17

Safety and Efficacy of Subcutaneous Sarilumab in Improving the Quality of Life in People With Indolent Systemic Mastocytosis

National Institutes of Health Clinical Center (CC)

Phase 2 Completed

21 enrolled 13 charts

Mastocytosis, Systemic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡